Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

9536 ARTÍCULOS , VIENDO DEL 9316 AL 9330

Association of cognitive impairment and peripheral artery disease (PAD): A systematic review

Cheshire BL, Messeder SJ, Pepper CJ, Beishon LC, Sayers RD, Houghton JS.

Vasc Med. 2025 Dec;30(6):724-739. doi: 10.1177/1358863X251336736. Epub 2025 May 21.

Validation of harmonized cognitive assessment protocol within the Egyptian context

Moustafa SA, Douhou S, Hassanin HI, Ali MAA, El Sheikh NG, Elkholy N, Tawfik HM, Shaat MM, Sanad HT, Abdelmalak MWM, Elfarrash S, Salama S, Ewis A, Hassan OA, Abdelfattah M, Mohamed AS, Saif MYS, Abouzied AM, MohamedMohamed EA, Salama M.

Soc Psychiatry Psychiatr Epidemiol. 2025 May;60(5):1227-1237. doi: 10.1007/s00127-024-02783-2. Epub 2024 Nov 29.

Mind Your Mouth: Impact of Oral Bacteria on Alzheimer's Disease

Mohammed AI, Mohammed AI, Reynolds E.

J Oral Pathol Med. 2026 Jan;55(1):1-6. doi: 10.1111/jop.70111. Epub 2025 Dec 23.

Natural Products in Alzheimer's Disease: A Systematic Review of Clinical Trials and Underlying Molecular Mechanisms

Bayo Jimenez MT, Rivas-García L, Sánchez-González C, Grosso G, Lipari V, Vera-Ramírez L, Battino M, Giampieri F, Quiles JL, Forbes-Hernández TY.

Int J Mol Sci. 2025 Oct 31;26(21):10631. doi: 10.3390/ijms262110631.

Disparities in the Diagnosis and Treatment of Osteoporosis in Persons with Cognitive Impairment and Dementia

Shrestha P, Basida B, Elam RE, Hajj JE, Le B, Fink HA, Bethel M, Tharrington SG, Carbone LD.

Curr Osteoporos Rep. 2025 Jul 9;23(1):31. doi: 10.1007/s11914-025-00924-3.

Adverse childhood experiences and risk of late-life dementia: a systematic review and meta-analysis

Abouelmagd ME, AbdelMeseh M, Elrosasy A, Eldeeb HA, Nabil Y.

Soc Psychiatry Psychiatr Epidemiol. 2025 May;60(5):1087-1098. doi: 10.1007/s00127-024-02676-4. Epub 2024 May 8.

Age-dependent efficacy of Bifidobacterium strains on cognitive impairment and dementia: A systematic review and meta-analysis

Yu W, Li Y, Liu Z, Hua S, Tan Z, Tang W, Gao M, Zhou X, Hua Z.

Ageing Res Rev. 2025 Sep;111:102850. doi: 10.1016/j.arr.2025.102850. Epub 2025 Jul 31.

Safety and Tolerability of Brexpiprazole in Participants with Agitation Associated with Dementia due to Alzheimer's Disease: Pooled Analysis of Three Randomized Trials and an Extension Trial

Shah A, Estilo A, Sheridan PL, Kalu U, Chen D, Chang D, Slomkowski M, Lee D, Hefting N, Hobart M, Behl S, Such P, Brubaker M, Grossberg GT.

CNS Drugs. 2025 Oct;39(10):1011-1023. doi: 10.1007/s40263-025-01200-9. Epub 2025 Jul 19.

Repurposing glucagon-like peptide-1 receptor agonists for the treatment of neurodegenerative disorders

Sabbagh MN, Cummings JL, Ballard C, van der Flier WM, Heneka MT, Holst JJ, Knudsen LB, Salloway S, Tansey MG, Drucker DJ.

Nat Aging. 2026 Jan;6(1):56-67. doi: 10.1038/s43587-025-01029-3. Epub 2025 Dec 19.

Lipoprotein levels and statin treatment related to dementia and cognitive decline in individuals with type 2 diabetes: an observational analysis from the ADVANCE study

Af Geijerstam P, Chalmers J, Pikkemaat M, Peters R, Marre M, Mancia G, Woodward M, Harris K.

Cardiovasc Diabetol. 2025 Aug 18;24(1):340. doi: 10.1186/s12933-025-02894-3.

Association Between Choroid Plexus Morphological Alterations, Alzheimer Pathologies, and Cognitive Impairment: A Longitudinal Study

Lin M, Zeng Q, Zhong S, Nie S, Zhang R, Hong H, Liu L, Wang S, Li K, Luo X, Chen Y, Huang P; Alzheimer's Disease Neuroimaging Initiative (ADNI).

Neurology. 2025 Dec 23;105(12):e213953. doi: 10.1212/WNL.0000000000213953. Epub 2025 Nov 24.

Evidence on Protective Factors for Dementia and Cognitive Impairment in Older Adults: An Umbrella Review

Sacchetti S, Locatelli G, Altomare D, Guaita A, Rolandi E.

Dement Geriatr Cogn Disord. 2025;54(6):394-408. doi: 10.1159/000545503. Epub 2025 Apr 3.

Association of sarcopenic obesity with cognitive dysfunction and dementia: a systematic review and meta-analysis

Tang C, Song Y, Tao F, Hao J, Yan L, Shi X, Pei R, Zeng B.

Aging Clin Exp Res. 2025 Nov 6;37(1):318. doi: 10.1007/s40520-025-03222-1.

Communication Bridge-2 randomized controlled trial: Recruitment and baseline features

Rogalski E, Bona M, Esparza M, Mooney A, Fried-Oken M, Rademaker A, Roberts A.

Alzheimers Dement. 2025 Jan;21(1):e14168. doi: 10.1002/alz.14168. Epub 2024 Nov 26.

Oral PRI-002 treatment in patients with MCI or mild AD: a randomized, double-blind phase 1b trial

Kutzsche J, Cosma NC, Kauselmann G, Fenski F, Bieniek C, Bujnicki T, Pils M, Bannach O, Willbold D, Peters O.

Nat Commun. 2025 May 6;16(1):4180. doi: 10.1038/s41467-025-59295-z.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias